XINKONG INT CAP (00993) announces annual performance, with a shareholder net loss of 1.153 billion Hong Kong dollars, a year-on-year increase of 79.42%.
Credit Suisse International Capital Limited (00993) announced its annual performance until December 31, 2025. The group recorded revenue of HKD 196.88 million, a decrease of 78.7% year-on-year. The company's equity holders' loss attributable was HKD 1.153 billion, an increase of 79.42% year-on-year. Basic loss per share was 13.2 Hong Kong cents.
XINKONG INT CAP (00993) announced the annual performance ending on December 31, 2025. The group achieved a revenue of HKD 196.88 million, a decrease of 78.7% year-on-year; the loss attributable to equity holders of the Company was HKD 1.153 billion, an increase of 79.42% year-on-year; basic loss per share was 13.2 HK cents.
The announcement stated that the net loss for the year increased mainly due to (1) decrease in revenue; (2) significant net loss on financial assets recognized at fair value through profit or loss for the year, compared to net gains in the previous year; and (3) a further decline in the expected recoverable amount of a loan within the Group, resulting in a significant impairment loss recognized for the year.
Related Articles

TIMES NEIGHBOR (09928) released its annual performance, with a shareholder profit of 17.09 million yuan, a year-on-year increase of 263.85%.

Red Star Macalline Group Corporation (01528) achieved a self-operated mall revenue of 4.94 billion yuan in 2025, a year-on-year decrease of 9.6%.

C WAN TONG YUAN (06966) announces annual performance with a net loss attributable to shareholders of 11.783 million yuan, a turnaround from a profit to a loss year on year.
TIMES NEIGHBOR (09928) released its annual performance, with a shareholder profit of 17.09 million yuan, a year-on-year increase of 263.85%.

Red Star Macalline Group Corporation (01528) achieved a self-operated mall revenue of 4.94 billion yuan in 2025, a year-on-year decrease of 9.6%.

C WAN TONG YUAN (06966) announces annual performance with a net loss attributable to shareholders of 11.783 million yuan, a turnaround from a profit to a loss year on year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


